Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q2 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading analysis...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 12 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$3.9M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 8 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -5%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 8 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
EOD close · as of 2026-10-14
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $37.9M 100.0% | $25.1M 100.0% | $46.5M 100.0% | $64.9M 100.0% | $57.1M 100.0% | $50.0M 100.0% | $46.1M 100.0% | $50.4M 100.0% |
| Cost of Revenue | $31.6M 83.4% | $21.0M 83.6% | $44.7M 96.2% | $58.6M 90.4% | $51.5M 90.1% | $42.5M 84.9% | $36.4M 79.0% | $42.2M 83.9% |
| Gross Profit | $6.3M 16.6% | $4.1M 16.4% | $1.8M 3.8% | $6.2M 9.6% | $5.6M 9.9% | $7.5M 15.1% | $9.7M 21.0% | $8.1M 16.1% |
| Research & Development | $673K 1.8% | $1.4M 5.4% | $568K 1.2% | $1.2M 1.9% | $8K 0.0% | $54K 0.1% | $44K 0.1% | — |
| Selling, General & Admin | $18.2M 48.1% | $3.3M 13.2% | $3.8M 8.2% | $4.1M 6.4% | $3.3M 5.7% | $2.7M 5.5% | $3.5M 7.6% | $2.2M 4.3% |
| Operating Income | -$12.6M -33.2% | -$564K -2.2% | -$2.6M -5.6% | $2.1M 3.2% | $2.4M 4.2% | $4.8M 9.6% | $6.2M 13.4% | $6.0M 11.9% |
| Interest Expense | — | — | — | — | $58K 0.1% | $243K 0.5% | $224K 0.5% | $216K 0.4% |
| Other Income (Expense), net | -$7.4M -19.4% | -$1.6M -6.3% | -$5.3M -11.4% | -$541K -0.8% | $975K 1.7% | $994K 2.0% | $763K 1.7% | $175K 0.3% |
| Pretax Income | -$19.9M -52.6% | -$2.1M -8.5% | -$7.9M -17.0% | $1.6M 2.4% | $3.4M 5.9% | $5.8M 11.6% | $6.9M 15.1% | $6.1M 12.2% |
| Income Tax Expense | $278K 0.7% | -$620K -2.5% | $219K 0.5% | $194K 0.3% | $255K 0.4% | $865K 1.7% | $1.0M 2.2% | $943K 1.9% |
| Net Income | -$19.9M -52.6% | -$1.4M -5.7% | -$7.8M -16.7% | $1.1M 1.7% | $3.2M 5.5% | $5.1M 10.1% | $5.9M 12.8% | $5.2M 10.3% |
| Per Share | ||||||||
| EPS (Basic) | -$0.18 | -$0.20 | -$1.08 | $0.15 | $0.09 | $0.17 | $0.18 | — |
| EPS (Diluted) | -$0.18 | -$0.20 | -$1.08 | $0.15 | $0.09 | $0.17 | $0.18 | — |
| Weighted Avg Shares (Basic) | 113.3M | 7.2M | 7.2M | 7.2M | 34.1M | 30.0M | 30.0M | — |
| Weighted Avg Shares (Diluted) | 113.3M | 7.2M | 7.2M | 7.2M | 34.1M | 30.0M | 30.0M | — |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
EOD close · as of 2026-10-14
Where each multiple sits in its own 5-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
ROE -5% against ROIC -5% — 0% of the return on equity comes from leverage and buybacks rather than from the operating business.
Equity is the year-end figure. On average equity over the two year-ends, ROE is -9.2% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 41.7× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 83.9 | 79.0 | 84.9 | 90.1 | 90.4 | 96.2 | 83.6 | 83.4 |
| Gross Profit | 16.1 | 21.0 | 15.1 | 9.9 | 9.6 | 3.8 | 16.4 | 16.6 |
| R&D | — | 0.1 | 0.1 | 0.0 | 1.9 | 1.2 | 5.4 | 1.8 |
| SG&A | 4.3 | 7.6 | 5.5 | 5.7 | 6.4 | 8.2 | 13.2 | 48.1 |
| Operating Income | 11.9 | 13.4 | 9.6 | 4.2 | 3.2 | -5.6 | -2.2 | -33.2 |
| Income Tax | 1.9 | 2.2 | 1.7 | 0.4 | 0.3 | 0.5 | -2.5 | 0.7 |
| Net Income | 10.3 | 12.8 | 10.1 | 5.5 | 1.7 | -16.7 | -5.7 | -52.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on BGM: price, valuation and headline fundamentals from SEC filings. The four questions at the top of the page are where the judgements live.
Solve the discounted cash flow backwards, then stress-test the assumptions.
Average free cash flow across the last 2 positive fiscal years (FY2023, FY2024). Smooths the cycle. Stock compensation is NOT charged — it is added back inside operating cash flow.
To be worth $9.55 today, the market must believe free cash flow compounds 57.5%/yr for a decade (off $218K on the 3-yr avg basis).
Default is 10.7% — this company's computed cost of capital (computed WACC), the same rate the Analysis tab discounts at.
2-stage DCF · 0.01B shares (market data) · net debt -$9.8M
mean -325.1% · volatility σ 608% · implied rate exceeded in 1/5 yrs
Central path = implied 57.5%/yr growth; shaded band = ±1σ (608%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Interest last disclosed in FY2021 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
No positive operating income in the last three years, so there is no return on capital to compare against its cost.
| Fiscal year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY2018 | 16.1% | 11.9% | 10.3% |
| FY2019 | 21.0% | 13.4% | 12.8% |
| FY2020 | 15.1% | 9.6% | 10.1% |
| FY2021 | 9.9% | 4.2% | 5.5% |
| FY2022 | 9.6% | 3.2% | 1.7% |
| FY2023 | 3.8% | -5.6% | -16.7% |
| FY2024 | 16.4% | -2.2% | -5.7% |
| FY2025 | 16.6% | -33.2% | -52.6% |
Return on equity (-5%) and return on invested capital (-5%) are within a couple of points in FY2025, so the headline return is the operating return — there is no meaningful leverage effect to strip out.
No material counter-signal in the checked set: ROIC vs WACC spread, 5-year spread history, gross margin trend, operating margin trend, net margin against 3 years ago, revenue growth, ROIC ex-goodwill gap.
Missing from our data, so excluded from this answer: positive EBIT.
Cash conversion is 2.55x, but receivables have outgrown revenue 3 years running.
Reported free cash flow is -$4M; after share-based compensation it is -$14M. The difference is a real cost that the cash flow statement adds back.
Debt is present but there is no positive EBITDA or no reported interest expense, so coverage cannot be measured.
Balance sheet at 2025-09-30. Undrawn revolving credit is not shown: the tag is collected but not yet mapped through to the API.
No material counter-signal in the checked set: net debt / EBITDA, interest coverage, stressed coverage, maturity schedule vs cash and one year of FCF, liquidity ratios.
Missing from our data, so excluded from this answer: ebitda, interest_expense.
At $9.55, free cash flow must compound 57.56%/yr for 10 years. It has no positive compounding record to compare against.
| Fiscal year | FCF growth | Price requires |
|---|---|---|
| FY2021 | −124.8% | 57.6% |
| FY2023 | −98.8% | 57.6% |
| FY2024 | 129.6% | 57.6% |
| FY2025 | −1395.3% | 57.6% |
Stock compensation is material for this company but was not reported in every year of the basis window, so it could not be charged. The requirement below is therefore solved on cash flow that treats shares issued to employees as free.
| Step | Amount | Running total |
|---|---|---|
| Net income | −$20M | −$20M |
| Share-based comp | $10M | −$10M |
| Other non-cash & working capital | $7M | −$2M |
| Operating cash flow | −$2M | −$2M |
| Capex | −$2M | −$4M |
| Free cash flow | −$4M | −$4M |
| FCF after SBC | −$14M | −$14M |
| Fiscal year | Revenue growth | Receivables growth | Gap |
|---|---|---|---|
| FY2020 | 8.5% | 85.3% | 76.7 points |
| FY2021 | 14.1% | 55.0% | 40.9 points |
| FY2022 | 13.6% | -53.0% | -66.5 points |
| FY2023 | -28.4% | 142.3% | 170.7 points |
| FY2024 | -46.0% | -21.9% | 24.1 points |
| FY2025 | 51.1% | 175.6% | 124.5 points |
| Fiscal year | DSO | DIO | DPO | Cash conversion cycle |
|---|---|---|---|---|
| FY2019 | 4.8 days | 125.5 days | 35.8 days | 94.5 days |
| FY2020 | 8.2 days | 103 days | 37.6 days | 73.6 days |
| FY2021 | 11.1 days | 88.6 days | 47.1 days | 52.6 days |
| FY2022 | 4.6 days | 55.3 days | 32.9 days | 26.9 days |
| FY2023 | 15.5 days | 40.7 days | 29.3 days | 26.9 days |
| FY2024 | 22.4 days | 87.8 days | 71.8 days | 38.5 days |
| FY2025 | 40.9 days | 232.1 days | 75.7 days | 197.4 days |
| Fiscal year | Accruals / assets |
|---|---|
| FY2019 | 18.4 percent |
| FY2020 | -0.0 percent |
| FY2021 | 3.7 percent |
| FY2022 | -17.9 percent |
| FY2023 | -15.8 percent |
| FY2024 | -3.8 percent |
| FY2025 | -4.0 percent |
SBC is added back inside operating cash flow, so reported free cash flow treats shares issued to employees as free. Percent of revenue says how expensive the payroll is; percent of operating cash flow says how much of the cash exists only because the charge was added back. The buyback offset is buybacks over SBC — below 1.0 the repurchase does not cover the shares issued.
Figures are the latest fiscal year (FY2025) from the company's own filings, not a trailing-twelve-month window — Q2 reads fiscal years throughout so the cash-conversion ratios and these share one basis. A blank is a line the filer did not report; it is never read as zero.